Dr. Zaid A. Noori, MD

Dr. Noori practices at University of Toledo Medical Center in Toledo, Ohio, part of The University of Toledo Medical Center.

Dr. Noori's NPI, 1114454709, was assigned on May 15, 2017. Dr. Noori holds Ohio license 35.148067.

Dr. Noori's primary practice is University of Toledo Medical Center, at 3000 Arlington Avenue, Toledo, OH 43614 in Lucas County. The practice phone is (419) 383-3407.

Dr. Noori's primary practice is University of Toledo Medical Center in Toledo, Ohio, part of The University of Toledo Medical Center. Dr. Noori is also affiliated with ProMedica Toledo Hospital. The medical group on file is UT Physicians Group. Dmand AI also links Dr. Noori to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Noori practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Noori's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Noori's licenses on file in 2 states: Ohio and Michigan.

CMS data shows 850 Medicare services from Dr. Noori across 18 procedure codes in 2024, for 305 Medicare patients. Medicare paid $69,052 for them.

CMS counts 305 Medicare patients who saw Dr. Noori in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Noori's median patient age at 71, with 50% women.

In 2024, Dr. Noori wrote 203 Medicare Part D claims for 52 patients. 50% of them were for generic drugs. CMS names the drug for 109 of them, across 6 drugs with 11 or more claims each, at $294,773 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Noori for performance year 2024, reported as part of a group. Dr. Noori accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Noori, published from 2022 to 2024. 2022 was the busiest year, with 2. The most frequent topics are COVID-19 Drug Treatment, Dexamethasone and Methylprednisolone. Dr. Noori has published most often in Am J Ther. Dr. Noori's most frequent co-authors are Nezam Ibrahim Altorok, Ragheb A. Assaly, MD and Hazem Ayesh, MD.

CMS Open Payments shows 32 general payments to Dr. Noori from 17 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. United Therapeutics Corporation paid the most, $438.